Skip to content

Clinical trials

Phase 2 Acute Coronary Syndrome trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Acute Coronary Syndrome Phase: Phase 2 Country / region: United States Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20052
20062
20073
20083
20092
20111
20123
20141
20152
20162
20181
20191
20201
20221
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23
Terminated3
Recruiting2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cerenis Therapeutics, SA2
Johns Hopkins University2
University of Alabama at Birmingham2
University of Texas Southwestern Medical Center2
ARCA Biopharma, Inc.1
Abcentra1
Beth Israel Deaconess Medical Center1
Bristol-Myers Squibb1
Eisai Inc.1
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Acute Coronary Syndrome29
Angina, Unstable6
Myocardial Infarction6
Coronary Artery Disease4
Coronary Disease4
Heart Diseases3
Arterial Occlusive Diseases1
Arteriosclerosis1
Atherosclerosis1
Coronary Restenosis1

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.